Axsome Therapeutics Starts Phase 3 Trial of AXS-05 for Smoking Cessation
MT newswire2026/08/31 11:29By:MT newswire
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
07:29 AM EDT, 08/31/2026 (MT Newswires) -- Axsome Therapeutics (AXSM) said Monday that it has dosed the first patient in its phase 3 trial evaluating AXS-05, its experimental drug intended for smoking cessation. The trial will compare AXS-05 with bupropion and placebo in adult smokers over about 12 weeks. The main goal of the study is to measure smoking abstinence at the end of the treatment period.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
--Investar Keeps Quarterly Dividend at $0.12 a Share, Payable Oct. 30 to Holders as of Sept. 30
MT newswire•2026/09/17 07:32
2-Yr Benchmark Govt Yields - U.S. vs Other Nations
Dow Jones•2026/09/17 07:10
Danieli Started at Buy by Jefferies
Dow Jones•2026/09/17 06:59
Crypto prices
More
Bitcoin
BTC
$76,463.3
+0.95%
Ethereum
ETH
$2,445.84
+2.04%
Tether USDt
USDT
$0.9991
+0.00%
BNB
BNB
$725.54
+1.88%
XRP
XRP
$1.3
+0.95%
USDC
USDC
$0.9998
-0.00%
Solana
SOL
$100.02
+3.07%
TRON
TRX
$0.3351
+0.14%
Zcash
ZEC
$1,359.03
+15.02%
Hyperliquid
HYPE
$79.37
+2.08%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now